Evaluation of direct-to-consumer low-volume lab tests in healthy adults.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Impact of Adherence to a Plant-Based Residential Lifestyle Medicine Program on Cardiometabolic Disease Risk Factors.Nutrients · 2026
   Observational
2. Automated end-to-end blood testing at the point-of-care: Integration of robotic phlebotomy with downstream sample processing.Technology · 2018
   Article
3. PRECISION MEDICINE: DATA AND DISCOVERY FOR IMPROVED HEALTH AND THERAPY.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2017
   Article

Corrections and comments

• Erratum for
  Evaluation of direct-to-consumer low-volume lab tests in healthy adults.2016

Authors and funding

13 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.